Min Yoo, MD
Surgical Oncology · Springdale, ARNPI 1962606756
Payments from drug & device makers
What this record shows
27 manufacturers reported payments, led by Stryker at 43.5% of the total. Reporting peaked in 2023 at $1,217 and has fallen 75.4% since, to $300 in 2025.
Across 51 payments — averaging $48.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1K
- Hologic Inc$566
- Merck$204
- Viiv Healthcare Company$116
- Daiichi Sankyo Inc.$63
- Puma Biotechnology, Inc.$46
- plus $415 from 21 others
What the payments were for
- Travel & lodging$1,31553%
- Food & beverage$1,18347%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- 1688$769
- Trunode$545
- SPY-PHI SYSTEM$232
- DOVATO$116
How this compares
Too few surgical oncology providers in Arkansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 58 | $321 |
| Letrozole | 20 | $314 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $87 |
| Cephalexin | 12 | $57 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Springdale
- Michael CrossSpringdale$637
- Brian BadgwellLittle Rock$24K
- Ronda Henry TillmanLittle Rock$9K
- Juan Barreto AndradeLittle Rock$5K
- Eric BurdgeLittle Rock$3K
- Rakhshanda Layeequr-RahmanLittle Rock$3K
- Camila OrtegaLittle Rock$1K
- Vicki KlimbergLittle Rock$453
- Chad CragleLittle Rock$169
- Anne MancinoLittle Rock$51
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.